A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.124.267416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Neeta Pandit-Taskar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastasis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Radiology, Weill Cornell Medical Center, New York, New York.
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
- Janssen Research & Development, LLC, Spring House, Pennsylvania.
- Invicro, LLC, Boston, Massachusetts.
- Memorial Sloan Kettering Cancer Center, New York, New York.
Förderung
- NCI NIH HHS
Zitieren
APA
Pandit-Taskar, N., O'Donoghue, J. A., Chetty, D., Max, S., Wanik, D., Ilovich, O., Russell, M., Nyima, T., Divgi, C. R., Yu, M., & Morris, M. J. (2024). A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267416
Vancouver
Pandit-Taskar N, O'Donoghue JA, Chetty D, Max S, Wanik D, Ilovich O, et al. A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267416
BibTeX
@article{PanditTaskar2024,
author = {Pandit-Taskar, Neeta and O'Donoghue, Joseph A and Chetty, Dushen and Max, Steven and Wanik, Danielle and Ilovich, Ohad and Russell, Michael and Nyima, Tenzin and Divgi, Chaitanya R and Yu, Margaret and Morris, Michael J},
title = {A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.124.267416}
}
EUVIMED